Literature DB >> 15961312

Two patients with 'Dropped head syndrome' due to mutations in LMNA or SEPN1 genes.

A D'Amico1, G Haliloglu, P Richard, B Talim, S Maugenre, A Ferreiro, P Guicheney, I Menditto, S Benedetti, E Bertini, G Bonne, H Topaloglu.   

Abstract

Dropped head syndrome is characterized by severe weakness of neck extensor muscles with sparing of the flexors. It is a prominent sign in several neuromuscular conditions, but it may also be an isolated feature with uncertain aetiology. We report two children in whom prominent weakness of neck extensor muscles is associated with mutations in lamin A/C (LMNA) and selenoprotein N1 (SEPN1) genes, respectively. This report expands the underlying causes of the dropped head syndrome which may be the presenting feature of a congenital muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961312     DOI: 10.1016/j.nmd.2005.03.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  16 in total

Review 1.  Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

Authors:  Vanja Pekovic; Christopher J Hutchison
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

2.  Lamina-associated polypeptide 1 is dispensable for embryonic myogenesis but required for postnatal skeletal muscle growth.

Authors:  Ji-Yeon Shin; Iván Méndez-López; Mingi Hong; Yuexia Wang; Kurenai Tanji; Wei Wu; Leana Shugol; Robert S Krauss; William T Dauer; Howard J Worman
Journal:  Hum Mol Genet       Date:  2017-01-01       Impact factor: 6.150

3.  SEPN1-related myopathy in three patients: novel mutations and diagnostic clues.

Authors:  Anna Ardissone; Cinzia Bragato; Flavia Blasevich; Elio Maccagnano; Franco Salerno; Claudia Gandioli; Lucia Morandi; Marina Mora; Isabella Moroni
Journal:  Eur J Pediatr       Date:  2016-01-16       Impact factor: 3.183

4.  A Novel Missense Variant in the AGRN Gene; Congenital Myasthenic Syndrome Presenting With Head Drop.

Authors:  Mert Karakaya; Ozge Ceyhan-Birsoy; Alan H Beggs; Haluk Topaloglu
Journal:  J Clin Neuromuscul Dis       Date:  2017-03

Review 5.  Understanding the importance of selenium and selenoproteins in muscle function.

Authors:  M Rederstorff; A Krol; A Lescure
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

6.  Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle.

Authors:  Michael J Jurynec; Ruohong Xia; John J Mackrill; Derrick Gunther; Thomas Crawford; Kevin M Flanigan; Jonathan J Abramson; Michael T Howard; David Jonah Grunwald
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-19       Impact factor: 11.205

7.  A laminopathic mutation disrupting lamin filament assembly causes disease-like phenotypes in Caenorhabditis elegans.

Authors:  Erin M Bank; Kfir Ben-Harush; Naama Wiesel-Motiuk; Rachel Barkan; Naomi Feinstein; Oren Lotan; Ohad Medalia; Yosef Gruenbaum
Journal:  Mol Biol Cell       Date:  2011-06-08       Impact factor: 4.138

8.  Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies.

Authors:  G Lattanzi; S Benedetti; E Bertini; G Boriani; L Mazzanti; G Novelli; R Pasquali; A Pini; L Politano
Journal:  Acta Myol       Date:  2011-10

Review 9.  Lamins and bone disorders: current understanding and perspectives.

Authors:  Chiara Gargiuli; Elisa Schena; Elisabetta Mattioli; Marta Columbaro; Maria Rosaria D'Apice; Giuseppe Novelli; Tiziana Greggi; Giovanna Lattanzi
Journal:  Oncotarget       Date:  2018-04-27

10.  Diagnostic approach to the congenital muscular dystrophies.

Authors:  Carsten G Bönnemann; Ching H Wang; Susana Quijano-Roy; Nicolas Deconinck; Enrico Bertini; Ana Ferreiro; Francesco Muntoni; Caroline Sewry; Christophe Béroud; Katherine D Mathews; Steven A Moore; Jonathan Bellini; Anne Rutkowski; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2014-01-09       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.